Home ETF List About

Portfolio Holdings Detail for ISIN IE00BMBKBZ46
Stock Name / FundiShares S&P 500 Health Care Sector UCITS ETF
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIUHE.AS(EUR) CXE
ETF TickerIUHE(EUR) Euronext Amsterdam

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares S&P 500 Health Care Sector UCITS ETF INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2025-11-11 (Tuesday)82,074USD 8,877,124INCY holding increased by 178921USD 8,877,1240USD 178,921 USD 108.16 USD 105.98
2025-11-10 (Monday)82,074INCY holding increased by 910USD 8,698,203INCY holding increased by 96442USD 8,698,203910USD 96,442 USD 105.98 USD 105.98
2025-11-07 (Friday)81,164USD 8,601,761INCY holding increased by 63308USD 8,601,7610USD 63,308 USD 105.98 USD 105.2
2025-11-06 (Thursday)81,164INCY holding increased by 91USD 8,538,453INCY holding decreased by -30963USD 8,538,45391USD -30,963 USD 105.2 USD 105.7
2025-11-05 (Wednesday)81,073INCY holding decreased by -91USD 8,569,416INCY holding increased by 216017USD 8,569,416-91USD 216,017 USD 105.7 USD 102.92
2025-11-04 (Tuesday)81,164INCY holding increased by 91USD 8,353,399INCY holding increased by 118814USD 8,353,39991USD 118,814 USD 102.92 USD 101.57
2025-11-03 (Monday)81,073USD 8,234,585INCY holding increased by 655881USD 8,234,5850USD 655,881 USD 101.57 USD 93.48
2025-10-31 (Friday)81,073INCY holding increased by 460USD 7,578,704INCY holding increased by 114746USD 7,578,704460USD 114,746 USD 93.48 USD 92.59
2025-10-30 (Thursday)80,613INCY holding decreased by -552USD 7,463,958INCY holding increased by 144498USD 7,463,958-552USD 144,498 USD 92.59 USD 90.18
2025-10-29 (Wednesday)81,165INCY holding decreased by -184USD 7,319,460INCY holding decreased by -136176USD 7,319,460-184USD -136,176 USD 90.18 USD 91.65
2025-10-28 (Tuesday)81,349INCY holding increased by 175USD 7,455,636INCY holding decreased by -100040USD 7,455,636175USD -100,040 USD 91.65 USD 93.08
2025-10-27 (Monday)81,174INCY holding decreased by -184USD 7,555,676INCY holding increased by 129318USD 7,555,676-184USD 129,318 USD 93.08 USD 91.28
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00BMBKBZ46

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY910108.810104.070 104.544USD 95,135 72.16
2025-11-06BUY91106.430103.075 103.410USD 9,410 71.84
2025-11-05SELL-91106.470101.500 101.997USD -9,282 71.68 Loss of -2,759 on sale
2025-11-04BUY91103.860100.020 100.404USD 9,137 71.53
2025-10-31BUY46095.10092.058 92.362USD 42,486 71.27
2025-10-30SELL-55294.62091.190 91.533USD -50,526 71.17 Loss of -11,242 on sale
2025-10-29SELL-18490.18094.420 93.996USD -17,295 71.07 Loss of -4,218 on sale
2025-10-28BUY17591.65093.980 93.747USD 16,406 70.97
2025-10-27SELL-18493.08093.170 93.161USD -17,142 70.86 Loss of -4,103 on sale
2025-10-22SELL-9288.06088.210 88.195USD -8,114 70.58 Loss of -1,621 on sale
2025-10-17SELL-36887.57088.540 88.443USD -32,547 70.32 Loss of -6,669 on sale
2025-10-16BUY46087.31092.860 92.305USD 42,460 70.23
2025-10-15BUY64488.15088.490 88.456USD 56,966 70.14
2025-10-14BUY9285.96086.160 86.140USD 7,925 70.06
2025-10-03BUY18286.85086.980 86.967USD 15,828 69.97
2025-10-02BUY9186.28088.660 88.422USD 8,046 69.88
2025-10-01BUY53086.70087.240 87.186USD 46,209 69.79
2025-09-24BUY2,23884.16084.820 84.754USD 189,679 69.42
2025-09-18BUY8986.00086.070 86.063USD 7,660 69.33
2025-09-12BUY23583.10085.510 85.269USD 20,038 69.01
2025-09-11BUY8986.17087.100 87.007USD 7,744 68.91
2025-09-10BUY8986.25086.940 86.871USD 7,732 68.81
2025-08-20BUY17686.20086.370 86.353USD 15,198 68.51
2025-08-19BUY8885.46085.690 85.667USD 7,539 68.41
2025-08-18BUY44084.92087.240 87.008USD 38,284 68.31
2025-08-15BUY1,32686.92087.060 87.046USD 115,423 68.21
2025-08-14BUY53486.16086.500 86.466USD 46,173 68.10
2025-08-13BUY35685.85086.020 86.003USD 30,617 67.99
2025-07-30BUY8977.55078.770 78.648USD 7,000 67.85
2025-07-17SELL-8968.94069.650 69.579USD -6,193 67.72 Loss of -166 on sale
2025-07-15SELL-35668.25070.150 69.960USD -24,906 67.70 Loss of -803 on sale
2025-07-14SELL-89069.98070.040 70.034USD -62,330 67.69 Loss of -2,086 on sale
2025-07-09SELL-8968.72069.300 69.242USD -6,163 67.66 Loss of -141 on sale
2025-07-07SELL-17867.27068.250 68.152USD -12,131 67.66 Loss of -87 on sale
2025-07-02BUY8968.17069.100 69.007USD 6,142 67.65
2025-06-24SELL-1,51369.01069.540 69.487USD -105,134 67.61 Loss of -2,843 on sale
2025-06-23BUY8967.26068.780 68.628USD 6,108 67.61
2025-06-20SELL-17868.46069.190 69.117USD -12,303 67.60 Loss of -269 on sale
2025-06-18SELL-8968.27069.470 69.350USD -6,172 67.59 Loss of -156 on sale
2025-06-17BUY1,06868.81070.890 70.682USD 75,488 67.59
2025-06-13SELL-17867.75068.960 68.839USD -12,253 67.56 Loss of -228 on sale
2025-06-11SELL-8968.85070.360 70.209USD -6,249 67.54 Loss of -238 on sale
2025-06-10SELL-17870.07070.980 70.889USD -12,618 67.52 Loss of -600 on sale
2025-06-09SELL-26769.89069.960 69.953USD -18,677 67.50 Loss of -656 on sale
2025-05-21SELL-8964.78065.460 65.392USD -5,820 67.69 Profit of 204 on sale
2025-05-20SELL-17865.30066.110 66.029USD -11,753 67.71 Profit of 299 on sale
2025-05-15SELL-26762.76062.990 62.967USD -16,812 67.83 Profit of 1,298 on sale
2025-05-14SELL-26761.16062.500 62.366USD -16,652 67.89 Profit of 1,474 on sale
2025-05-13BUY8960.81061.150 61.116USD 5,439 67.95
2025-05-09SELL-8958.98060.480 60.330USD -5,369 68.10 Profit of 691 on sale
2025-05-08BUY17859.73059.990 59.964USD 10,674 68.18
2025-05-01BUY17862.03062.640 62.579USD 11,139 68.52
2025-04-24SELL-8958.97059.050 59.042USD -5,255 68.94 Profit of 881 on sale
2025-04-23BUY26758.00059.010 58.909USD 15,729 69.06
2025-04-15SELL-8958.46059.950 59.801USD -5,322 69.80 Profit of 890 on sale
2025-04-10SELL-17455.17058.330 58.014USD -10,094 70.23 Profit of 2,126 on sale
2025-04-08SELL-8756.97061.470 61.020USD -5,309 70.52 Profit of 826 on sale
2025-04-07SELL-8760.29061.060 60.983USD -5,306 70.64 Profit of 840 on sale
2025-04-04SELL-17460.58063.570 63.271USD -11,009 70.76 Profit of 1,303 on sale
2025-04-02BUY8762.33062.530 62.510USD 5,438 70.86
2025-04-01BUY78360.91062.000 61.891USD 48,461 70.98
2025-03-31SELL-52260.55060.810 60.784USD -31,729 71.11 Profit of 5,390 on sale
2025-03-28BUY8760.60060.970 60.933USD 5,301 71.24
2025-03-26SELL-5761.26062.880 62.718USD -3,575 71.50 Profit of 501 on sale
2025-03-21BUY60961.92062.330 62.289USD 37,934 71.87
2025-03-20BUY35660.58061.750 61.633USD 21,941 72.03
2025-03-17SELL-8862.01063.450 63.306USD -5,571 72.50 Profit of 809 on sale
2025-03-12BUY2,43567.73068.230 68.180USD 166,018 72.71
2025-03-07BUY8670.79072.810 72.608USD 6,244 72.84
2025-02-28SELL-25873.50073.630 73.617USD -18,993 72.97 Loss of -167 on sale
2025-02-25BUY86074.40076.240 76.056USD 65,408 72.92
2025-02-20BUY60271.38071.520 71.506USD 43,047 72.94
2025-02-19BUY25870.16071.430 71.303USD 18,396 72.99
2025-02-18BUY17271.27071.680 71.639USD 12,322 73.02
2025-02-13BUY43070.01072.690 72.422USD 31,141 73.19
2025-02-04BUY34474.12074.920 74.840USD 25,745 73.42
2025-01-31BUY8674.16075.180 75.078USD 6,457 73.40
2025-01-29BUY8673.72074.110 74.071USD 6,370 73.38
2025-01-27BUY17272.64073.430 73.351USD 12,616 73.41
2025-01-24BUY8672.59073.680 73.571USD 6,327 73.43
2025-01-02SELL-3,09369.53070.270 70.196USD -217,116 73.57 Profit of 10,441 on sale
2024-12-10SELL-8572.48073.100 73.038USD -6,208 73.60 Profit of 48 on sale
2024-12-09SELL-2,21072.11075.980 75.593USD -167,061 73.65 Loss of -4,291 on sale
2024-12-03SELL-1,02072.03072.960 72.867USD -74,324 73.55 Profit of 695 on sale
2024-12-02SELL-42573.24074.700 74.554USD -31,685 73.56 Loss of -422 on sale
2024-11-29SELL-8674.59076.080 75.931USD -6,530 73.52 Loss of -207 on sale
2024-11-22SELL-85071.72072.000 71.972USD -61,176 73.36 Profit of 1,181 on sale
2024-11-21SELL-42570.39071.400 71.299USD -30,302 73.51 Profit of 940 on sale
2024-11-20BUY68071.05071.680 71.617USD 48,700 73.64
2024-11-18SELL-1,02076.97077.010 77.006USD -78,546 73.62 Loss of -3,449 on sale
2024-11-11BUY76581.53083.540 83.339USD 63,754 72.63
2024-11-08SELL-2,72083.38083.950 83.893USD -228,189 71.87 Loss of -32,712 on sale
2024-11-07SELL-16882.34082.970 82.907USD -13,928 71.06 Loss of -1,990 on sale
2024-11-01SELL-16876.13076.330 76.310USD -12,820 68.19 Loss of -1,365 on sale
2024-10-31SELL-34474.12074.680 74.624USD -25,671 67.44 Loss of -2,470 on sale
2024-10-30BUY8573.93074.600 74.533USD 6,335 66.52
2024-10-29BUY51673.60074.070 74.023USD 38,196 65.34
2024-10-28SELL-25865.69065.880 65.861USD -16,992 65.27 Loss of -153 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.